Table of Contents
ISRN Biomedical Engineering
Volume 2013, Article ID 956362, 11 pages
http://dx.doi.org/10.1155/2013/956362
Research Article

Extrahepatic 25-Hydroxylation of Vitamin D3 in an Engineered Osteoblast Precursor Cell Line Exploring the Influence on Cellular Proliferation and Matrix Maturation during Bone Development

1Department of Biology, Portland State University, P.O. Box 751, Portland, OR 97207-0751, USA
2Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA

Received 31 March 2013; Accepted 4 May 2013

Academic Editors: D. K. Han and A. D. Lucas

Copyright © 2013 Shelley S. Mason et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. Winn, G. Randolph, H. Uludag, S. C. Wong, G. A. Hair, and J. O. Hollinger, “Establishing an immortalized human osteoprecursor cell line: OPC1,” Journal of Bone and Mineral Research, vol. 14, no. 10, pp. 1721–1733, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Atanga, S. Dolder, T. Dauwalder, A. Wetterwald, and W. Hofstetter, “TNFa inhibits the development of osteoclasts through osteoblast-derived GM-CSF,” Bone, vol. 49, pp. 1090–1100, 2011. View at Google Scholar
  3. P. Biswas and L. P. Zanello, “1α,25OH2 vitamin D3 induction of ATP secretion in osteoblasts,” Journal of Bone and Mineral Research, vol. 24, no. 8, pp. 1450–1460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Biswas and L. P. Zanello, “1α,25OH2 vitamin D3 induction of ATP secretion in osteoblasts,” Journal of Bone and Mineral Research, vol. 24, no. 8, pp. 1450–1460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Pockwinse, J. L. Stein, J. B. Lian, and G. S. Stein, “Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: interrelationship of morphology and gene expression by in situ hybridization,” Experimental Cell Research, vol. 216, no. 1, pp. 244–260, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. J. B. Lian and G. S. Stein, “Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation,” The Iowa Orthopaedic Journal, vol. 15, pp. 118–140, 1995. View at Google Scholar · View at Scopus
  7. G. Jones, S. A. Strugnell, and H. F. DeLuca, “Current understanding of the molecular actions of vitamin D,” Physiological Reviews, vol. 78, no. 4, pp. 1193–1231, 1998. View at Google Scholar · View at Scopus
  8. P. M. Brannon, “Key questions in vitamin D research,” Scandinavian Journal of Clinical & Laboratory Investigation, vol. 73, supplement 243, pp. 154–162, 2012. View at Google Scholar
  9. J. Hobaus, U. Thiem, D. M. Hummel, and E. Kallay, “Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis,” Anti-Cancer Agent in Medicinal Chemistry, vol. 13, no. 1, pp. 20–35, 2013. View at Google Scholar
  10. R. Kumar, “Vitamin D metabolism and mechanisms of calcium transport,” Journal of the American Society of Nephrology, vol. 1, no. 1, pp. 30–42, 1990. View at Google Scholar · View at Scopus
  11. A. W. Norman, “Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system,” The American Journal of Clinical Nutrition, vol. 67, pp. 1108–1110, 1998. View at Google Scholar
  12. M. S. Ahmed and A. Shoker, “Vitamin D metabolites, protective versus toxic properties: molecular and cellular perspectives,” Nephrology Reviews, vol. 2, no. 1, 2010. View at Google Scholar
  13. M. F. Hollick, Vitamin D, Springer, Boston, Mass, USA, 2010.
  14. S. Zhou, J. Glowacki, S. W. Kim et al., “Clinical characterizatics influence in vito action of 1, 25-dihydroxyvitamin D3 in human marrow stromal cells,” Journal of Bone and Mineral Research, vol. 27, no. 9, pp. 1992–2000, 2012. View at Google Scholar
  15. B. Lehmann, “Role of the vitamin D3 pathway in healthy and diseased skin—facts, contradictions and hypotheses,” Experimental Dermatology, vol. 18, no. 2, pp. 97–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Seifert, M. Rech, V. Meineke, W. Tilgen, and J. Reichrath, “Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro,” Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, pp. 375–379, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. N. Flanagan, M. V. Young, K. S. Persons et al., “Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D,” Anticancer Research, vol. 26, no. 4 A, pp. 2567–2572, 2006. View at Google Scholar · View at Scopus
  18. S. Geng, S. Zhou, and J. Glowacki, “Effects of 25-hydroxyvitamin D3 on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α- hydroxylase,” Journal of Bone and Mineral Research, vol. 26, no. 5, pp. 1145–1153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Chen, S. H. Kim, A. N. King et al., “CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma,” Clinical Cancer Research, vol. 17, no. 4, pp. 817–826, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. D. Boyan, J. Hurst-Kennedy, T. A. Denison, and Z. Schwartz, “Cellular responses to 24R,25-dihydroxyvitamin D3 in bone and cartilage,” Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, vol. 9, no. 3, pp. 137–142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. G. J. Atkins, P. H. Anderson, D. M. Findlay et al., “Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3,” Bone, vol. 40, no. 6, pp. 1517–1528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Naeem, “Vitamin D defficiency—an ingnored epidenmic,” International Journal of Health Sciences, vol. 4, no. 1, pp. 5–6, 2010. View at Google Scholar
  23. B. Lehmann and M. Meurer, “Extrarenal sites of calcitriol synthesis: the particular role of the skin,” Recent Results in Cancer Research, vol. 164, pp. 135–145, 2003. View at Google Scholar · View at Scopus
  24. C. D. Hoemann, H. El-Gabalawy, and M. D. McKee, “In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization,” Pathologie Biologie, vol. 57, no. 4, pp. 318–323, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. D. C. Halvorsen, D. Franklin, A. L. Bond et al., “Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells,” Tissue Engineering, vol. 7, no. 6, pp. 729–741, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Hewison, D. Zehnder, R. Chakraverty, and J. S. Adams, “Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase,” Molecular and Cellular Endocrinology, vol. 215, no. 1-2, pp. 31–38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. T. A. Owen, M. S. Aronow, L. M. Barone, B. Bettencourt, G. S. Stein, and J. B. Lian, “Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures,” Endocrinology, vol. 128, no. 3, pp. 1496–1504, 1991. View at Google Scholar · View at Scopus
  28. E. E. Golub and K. Boesze-Battaglia, “The role of alkaline phosphatase in mineralization,” Current Opinion in Orthopaedics, vol. 18, no. 5, pp. 444–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. H. T. Viljakainen, A. M. Natri, M. Kärkkäinen et al., “A positive dose-response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention,” Journal of Bone and Mineral Research, vol. 21, no. 6, pp. 836–844, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. L. Vanhooke, J. M. Prahl, C. Kimmel-Jehan et al., “CYP27B1 null mice with LacZ reporter gene display no 25-hydroxyvitamin D3-1α-hydroxylase promoter activity in the skin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 1, pp. 75–80, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. S. Mason, S. S. Kohles, R. D. Zelick, S. R. Winn, and A. K. Saha, “Three-dimensional culture of cells and matrix biomolecules for engineered tissue development and biokinetics model validation,” Journal of Nanotechnology in Engineering and Medicine, vol. 2, no. 2, pp. 25001–25007, 2011. View at Publisher · View at Google Scholar · View at Scopus